Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

TERMINATED

Status

115

Enrollment

INDUSTRY

Sponsor class

Stopped Because of slow recruitment; Despite the study was started long time ago (Oct 2004), we have not reached the projected number of patients (150 patients)

Conditions

Hepatitis C, Chronic
Hepacivirus

Interventions

BIOLOGICAL: Peginterferon alfa-2b (SCH 54031)
DRUG: Ribavirin (SCH 18908)
BEHAVIORAL: Patient assistance program

Sponsor

Merck Sharp & Dohme LLC